Financings Of The Fortnight: Bluebird IPO Could Provide Validation For Gene Therapy As A Modality

 
• By Alex Lash, Stacy Lawrence, Paul Bonanos, and Maureen Riordan
  
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Archive

More from Pink Sheet